Why under-40s will be offered alternative to Oxford-AstraZeneca vaccine
Experts say potential blood clot risk vs. benefits of the Covid jab is ‘more finely balanced’ for younger adults
Experts say potential blood clot risk vs. benefits of the Covid jab is ‘more finely balanced’ for younger adults
